Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CMC Biologics, Symphogen Enter Manufacturing Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

CMC Biologics, Symphogen Enter Manufacturing Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CMC Biologics has entered into an agreement with Symphogen for process development and cGMP manufacture of an undisclosed polyclonal antibody product candidate from Symphogen’s development pipeline. Terms of the agreement were not disclosed.
   
“We are pleased to establish such a partnership with Symphogen and are excited to be involved in this unique field of recombinant polyclonal antibody technology,” said Mads Laustsen, chief executive officer of CMC Biologics.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics